![Jason Werner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Werner
Directeur des opérations chez
ALIMERA SCIENCES, INC.
Profil
Jason M.
Werner is the founder of Eyevance Pharmaceuticals LLC, which was founded in 2017.
He held the title of Chief Operating Officer at Eyevance Pharmaceuticals LLC from 2017 to 2020.
Mr. Werner is currently the Director at OcuNexus Therapeutics, Inc. and the Chief Operating Officer at Alimera Sciences, Inc. He was previously the Chief Executive Officer at SightStream Biotherapeutics from 2021 to 2023 and the Chief Operating Officer at Eyevance Pharmaceuticals Holdings, Inc. from 2017 to 2020.
Mr. Werner obtained his undergraduate degree from the University of New Hampshire.
Postes actifs de Jason Werner
| Sociétés | Poste | Début |
|---|---|---|
| ALIMERA SCIENCES, INC. | Directeur des opérations | 02/10/2023 |
OcuNexus Therapeutics, Inc.
 OcuNexus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops, commercializes and manufactures therapeutic products for clinical ophthalmology | Directeur/Membre du Conseil | - |
Anciens postes connus de Jason Werner
| Sociétés | Poste | Fin |
|---|---|---|
SightStream Biotherapeutics
 SightStream Biotherapeutics BiotechnologyHealth Technology Develops cytoprotectives to reverse ocular cell death | Directeur Général | 30/09/2023 |
Eyevance Pharmaceuticals LLC
 Eyevance Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic products | Fondateur | 01/09/2020 |
Eyevance Pharmaceuticals Holdings, Inc.
 Eyevance Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops and commercializes topical ophthalmic products | Directeur des opérations | 01/09/2020 |
Formation de Jason Werner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Alimera Sciences, Inc.
 Alimera Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops, manufactures and commercializes therapeutics for ophthalmology, rheumatology, nephrology, neurology & pulmonology problems | Health Technology |
OcuNexus Therapeutics, Inc.
OcuNexus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops, commercializes and manufactures therapeutic products for clinical ophthalmology | Commercial Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eyevance Pharmaceuticals LLC
Eyevance Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic products | Health Technology |
Eyevance Pharmaceuticals Holdings, Inc.
Eyevance Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops and commercializes topical ophthalmic products | Health Technology |
SightStream Biotherapeutics
SightStream Biotherapeutics BiotechnologyHealth Technology Develops cytoprotectives to reverse ocular cell death | Health Technology |
